July 28, 2016 01:29 PM EDT
News Briefing

Pro­to­cols: Ed­i­tas gets a gene edit­ing col­lab­o­ra­tor; Reg­u­lus hus­tling up re­sponse to clin­i­cal hold; Sanofi drug OK’d

John Carroll

Editor & Founder

Gene edit­ing pi­o­neer Ed­i­tas has signed on with the ex­perts at the San Raf­faele Telethon In­sti­tute for Gene Ther­a­py (SR-TIGET) on a new al­liance …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times